No Clinically Relevant ADHD Risk With Prenatal Benzodiazepine, Z-Hypnotic Exposure
There is no substantial detrimental risk on child fine motor and attention-deficit/hyperactivity disorder (ADHD) symptoms after prenatal benzodiazepine/z-hypnotic exposure alone or in combination with opioids or antidepressants, according to study results published in JAMA Network Open.1
Other Articles in this Edition
Good Sleep a Must for Teens With ADHD
ADHD With and Without Emotion Dysregulation
Ritalin vs. Adderall: What’s the difference?
Concerta vs. Adderall: What’s the difference?
No Clinically Relevant ADHD Risk With Prenatal Benzodiazepine, Z-Hypnotic Exposure
Raising a child with ADHD costs five times more than raising a child without ADHD, study finds
Finding focus: Musical training may improve attentiveness
The Simple Accommodation Many Students With ADHD Aren’t Getting
Medication Isn’t the Only Answer for ADHD Treatment: 6 Alternatives to Consider